TEL AVIV, Israel, Sept. 22, 2025 /PRNewswire/ -- Techsomed, a leader in AI-Driven Precision for Image-Guided Care, today announces U.S. FDA 510 (k) clearance expanding indications for BioTraceIO360* ...
The absolute difference in cancer-specific survival for thermal ablation vs surgery for T1a RCC was just 1%. Cancer-specific survival among patients with stage T1a renal cell carcinoma (RCC) is ...
Microwave ablation plus chemotherapy significantly improves progression-free survival in advanced NSCLC without increasing toxicity compared to chemotherapy alone. The combination treatment leverages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results